Cancer Family
Respiratory System Neoplasm
CI-CAN-00000049Explore in graph →
Non-malignant2,727 active trials51 approved drugs619 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000049Explore in graph →
Clinical trials
11,611 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03228368 | The Predicted Potential of Quantitative T Cell Repertoire(TCR) in Anti-PD-L1 Treatment in NSCLC Patients | unknown | — | 10 | First Affiliated Hospital of Zhejiang UniversityOTHER | 1 | Jul 24, 2017 | clinicaltrials |
| NCT02346318 | The Randomized Controlled Clinical Trial of Kushen Injection | unknown | Phase 4 | 240 | Beijing Zheng Ju Medical Technology Co., Ltd.INDUSTRY | 1 | Jul 21, 2017 |
| clinicaltrials |
| NCT02622607 | Preventive Effects of Zoledronic Acid on Bone Metastasis in Patients With Stage IIIB and IV Lung Cancer | unknown | Phase 3 | 200 | Tang-Du HospitalOTHER | 1 | Jul 21, 2017 | clinicaltrials |
| NCT01014130 | Hypofractionated Radiotherapy (Stereotactic) Versus Conventional Radiotherapy for Inoperable Early Stage I Non-small Cell Lung Cancer (NSCLC)(CHISEL) | unknown | Phase 3 | 101 | Trans Tasman Radiation Oncology GroupOTHER | 2 | Jul 12, 2017 | clinicaltrials |
| NCT03211078 | ENB and Photodynamic Therapy in the Treatment for Early Lung Cancer | unknown | N/A | 10 | National Taiwan University HospitalOTHER | 1 | Jul 12, 2017 | clinicaltrials |
| NCT03205930 | Neo-MASCT Immunotherapy for Advanced NSCLC. | unknown | Phase 1 / Phase 2 | 20 | The First People's Hospital of LianyungangOTHER | 1 | Jul 5, 2017 | clinicaltrials |
| NCT03033615 | PixelShine vs. Iterative Reconstruction (IR) Processing of CT Images | unknown | N/A | 20 | AlgoMedica, Inc.INDUSTRY | 0 | Jun 28, 2017 | clinicaltrials |
| NCT03195569 | To Predict Efficacy by Detecting Circulating Endothelial Cell Subsets and Blood Perfusion Parameters Changes in Vivo Tumor in Study of QL1101 and Avastin® in Patients With Non-squamous Non-small Cell Lung Cancer | unknown | — | 15 | Qilu Pharmaceutical Co., Ltd.INDUSTRY | 1 | Jun 22, 2017 | clinicaltrials |
| NCT03189277 | A Hospital Based Survey on Lung Cancer Related-pain in Northern China | unknown | — | 2,000 | Chinese Academy of Medical SciencesOTHER | 0 | Jun 16, 2017 | clinicaltrials |
| NCT02896166 | Microwave Ablation in the Treatment of Stage I Non Small Cell Lung Cancer | unknown | Phase 3 | 150 | Shandong Provincial HospitalOTHER_GOV | 1 | Jun 14, 2017 | clinicaltrials |
| NCT02381808 | Study on Potential Biomarkers Associated With Clinical Phenotype of EGFR-TKIs in No-small Cell Lung Cancer in China | unknown | — | 150 | Guangdong Association of Clinical TrialsOTHER | 1 | Jun 7, 2017 | clinicaltrials |
| NCT03033186 | Everolimus TDM to Predict Long Term Toxicity(Foresight) | unknown | — | 40 | Maastricht University Medical CenterOTHER | 1 | May 31, 2017 | clinicaltrials |
| NCT03081741 | Circulating Tumor DNA in Surgical Lung Cancer Patients | unknown | — | 500 | Shenzhen Gene Health Bio Tech Co., Ltd.INDUSTRY | 1 | May 23, 2017 | clinicaltrials |
| NCT03153358 | Icotinib Combined With SBRT for Patients With Metastatic Non-squamous NSCLC With EGFR Mutation | unknown | Phase 2 | 60 | Sichuan Cancer Hospital and Research InstituteOTHER | 0 | May 16, 2017 | clinicaltrials |
| NCT03154242 | Effect of Genetic Polymorphisms on Platinum Based Chemotherapy in Non Small Cell Lung Cancer | unknown | — | 60 | Ain Shams UniversityOTHER | 1 | May 16, 2017 | clinicaltrials |
| NCT01963195 | Evaluation of the High Dose of Icotinib in Advanced Lung Cancer Patients After Failure of Target Therapy | unknown | Phase 2 | 30 | Anhui Medical UniversityOTHER | 1 | May 8, 2017 | clinicaltrials |
| NCT01785537 | The Efficacy and Safety of Electronic Cigarettes: a 5-year Follow-up Study | unknown | — | 1,050 | Università degli Studi 'G. d'Annunzio' Chieti e PescaraOTHER | 1 | May 5, 2017 | clinicaltrials |
| NCT03123679 | The Added Value of Quantification of Lung Function in Patients Undergoing Radiotherapy, Using Tc-99m-MAA SPECT-CT | unknown | N/A | 40 | Tel-Aviv Sourasky Medical CenterOTHER_GOV | 0 | May 2, 2017 | clinicaltrials |
| NCT02349724 | A Clinical Research of CAR T Cells Targeting CEA Positive Cancer | unknown | Phase 1 | 75 | Southwest Hospital, ChinaOTHER | 1 | Apr 25, 2017 | clinicaltrials |
| NCT03123445 | Endostar First-line Treatment of Advanced NSCLC | unknown | Phase 2 | 150 | China Medical University, ChinaOTHER | 0 | Apr 21, 2017 | clinicaltrials |
| NCT03123484 | β-elemene Combine With EGFR-TKI for Advanced EGFR-TKI-resistant NSCLC | unknown | Phase 2 | 80 | China Medical University, ChinaOTHER | 0 | Apr 21, 2017 | clinicaltrials |
| NCT03113318 | Mediastinal Lymph Node Dissection in Conjunction With Pulmonary Metastasectomy From Colorectal Cancer | unknown | N/A | 200 | Rigshospitalet, DenmarkOTHER | 1 | Apr 13, 2017 | clinicaltrials |
| NCT01527058 | 68Ga-BNOTA-PRGD2 PET/CT in Healthy Volunteers and Lung Cancer Patients(GRGDLC) | unknown | Early Phase 1 | 100 | Peking Union Medical College HospitalOTHER | 1 | Apr 7, 2017 | clinicaltrials |
| NCT01737112 | 99mTc-3PRGD2 SPECT/CT in Lung Cancer Patients(TcRGDLC) | unknown | Early Phase 1 | 100 | Peking Union Medical College HospitalOTHER | 1 | Apr 7, 2017 | clinicaltrials |
| NCT02577627 | Multi-Indication, Retrospective Oncological Study to Validate the Accuracy in Predicting TTP by PrediCare in Patients Under SOC | unknown | — | 5,000 | Optimata Ltd.INDUSTRY | 1 | Apr 4, 2017 | clinicaltrials |
| NCT02844114 | Clinical Study of Ganoderma Lucidum Spore Combined With Chemotherapy(LCKY2015-21(x)) | unknown | Phase 2 | 60 | Gao YajieOTHER | 1 | Mar 31, 2017 | clinicaltrials |
| NCT03070626 | Preoperative Loading With Carbohydrates in Lung Cancer Surgery | unknown | N/A | 104 | Oslo University HospitalOTHER | 1 | Mar 27, 2017 | clinicaltrials |
| NCT03090815 | Circulating Tumor DNA (ctDNA) as a Prognostic Tool in Patients With Advanced Lung Adenocarcinoma | unknown | — | 100 | The University of Hong KongOTHER | 1 | Mar 27, 2017 | clinicaltrials |
| NCT02714608 | A Study of Ginsenoside H Dripping Pills for Advanced Non-Small Cell Lung Cancer (NSCLC) | unknown | Phase 2 | 144 | Tasly Pharmaceuticals, Inc.INDUSTRY | 1 | Mar 21, 2017 | clinicaltrials |
| NCT02951611 | Effects of Acupuncture Stimulation on Systemic Inflammation | unknown | N/A | 60 | RenJi HospitalOTHER | 1 | Mar 17, 2017 | clinicaltrials |
| NCT03078959 | Prognostic Value of PD-L1 in NSCLC | unknown | — | 350 | Fondazione Ricerca TraslazionaleOTHER | 0 | Mar 14, 2017 | clinicaltrials |
| NCT02441972 | Clinic Study of 18F-Al-NOTA-PRGD2 in Cancer Diagnostics | unknown | Phase 1 | 200 | Wuxi No. 4 People's HospitalOTHER | 1 | Mar 10, 2017 | clinicaltrials |
| NCT02695550 | Study of Safety, Efficacy and Pharmacokinetics of CT-707 in Patients With ALK-positive Non-small Cell Lung Cancer | unknown | Phase 1 | 40 | Centaurus Biopharma Co., Ltd.INDUSTRY | 1 | Mar 9, 2017 | clinicaltrials |
| NCT03074864 | Targeted Treatment With Intercalated Radiotherapy in EGFR-mutant IIIA/IIIB NSCLC(TREND) | unknown | Phase 2 / Phase 3 | 90 | Guangdong Provincial People's HospitalOTHER | 1 | Mar 9, 2017 | clinicaltrials |
| NCT02055144 | Veristrat as Predictor of Benefit of First Line Non Small Cell Lung Cancer (NSCLC) Patients From Standard Chemotherapy | unknown | — | 100 | IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, ItalyOTHER | 1 | Mar 7, 2017 | clinicaltrials |
| NCT02502240 | ALK Rearrangements in Lung Adenocarcinoma: Epidemiology in Latin America (CLICaP) | unknown | — | 7,000 | Instituto Nacional de Cancerologia de MexicoOTHER | 1 | Mar 3, 2017 | clinicaltrials |
| NCT01980472 | Chemotherapy Plus Bevacizumab in Elderly Non-small Cell Lung Cancer Patients | unknown | Phase 2 | 50 | Grupo de Investigación y Divulgación OncológicaOTHER | 1 | Feb 27, 2017 | clinicaltrials |
| NCT02282267 | Blood Detection of EGFR Mutation For Iressa Treatment(Benefit) | unknown | N/A | 188 | Peking University Cancer Hospital & InstituteOTHER | 1 | Feb 24, 2017 | clinicaltrials |
| NCT02332512 | Study of Apatinib as 3rd/4th Line Treatment in Patients With Advanced Non-Squamous Non-small Cell Lung Cancer Harboring Wild-type Epidermal Growth Factor Receptor (EGFR)(ANSWER) | unknown | Phase 3 | 417 | Jiangsu HengRui Medicine Co., Ltd.INDUSTRY | 1 | Feb 24, 2017 | clinicaltrials |
| NCT02613637 | Registry Study on Biological Disease Profile and Clinical Outcome in Patients With Newly Diagnosed or Existent Lung Cancer The LuCa Biology and Outcome (BiO)-Project | unknown | — | 2,000 | University of UlmOTHER | 1 | Feb 24, 2017 | clinicaltrials |
| NCT03060343 | Zeushield Cytotoxic T Lymphocytes (Z-CTLs) for Relapsed or Refractory Non Small Cell Lung Cancer (NSCLC) | unknown | Early Phase 1 | 10 | Yu FengleiOTHER | 1 | Feb 23, 2017 | clinicaltrials |
| NCT03057340 | The Treatment of Advanced Lung Cancer With Dribbles Antigen by Targeting Activation of Tcells | unknown | Phase 1 | 30 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 0 | Feb 20, 2017 | clinicaltrials |
| NCT02974933 | Apatinib Mesylate Combined With Pemetrexed in the Treatment of Pretreated Advanced Non-squamous Non-small Cell Lung Cancer | unknown | Phase 2 | 48 | Wuling OuOTHER | 1 | Feb 17, 2017 | clinicaltrials |
| NCT03053804 | Clinical Application of MR-PET in Non-small Cell Lung Cancer: Diagnosis, Treatment Outcome, and Prognosis Prediction | unknown | N/A | 75 | National Taiwan University HospitalOTHER | 1 | Feb 15, 2017 | clinicaltrials |
| NCT03053856 | Adjuvant Pembrolizumab in N2 Positive Non-small Cell Lung Cancer Patients | unknown | Phase 2 | 37 | Samsung Medical CenterOTHER | 1 | Feb 15, 2017 | clinicaltrials |
| NCT03050411 | Apatinib Combine With EGFR-TKI for Advanced EGFR-TKI-resistant Non-Small Cell Lung Cancer | unknown | Phase 1 | 30 | Peking University Third HospitalOTHER | 1 | Feb 10, 2017 | clinicaltrials |
| NCT03050437 | A Study Comparing Pemetrexed Plus Cisplatin Versus Pemetrexed Alone in NSCLC Patients Who Have Progressed on First Line EGFR-TKI | unknown | Phase 2 | 96 | Samsung Medical CenterOTHER | 1 | Feb 10, 2017 | clinicaltrials |
| NCT03047525 | Study of DC-CTL Combined With CIK for Advanced Solid Tumor | unknown | Phase 1 / Phase 2 | 200 | Xiaoyi HuangOTHER | 1 | Feb 9, 2017 | clinicaltrials |
| NCT01714908 | Phase II Study of Erlotinib With Concurrent Radiotherapy in Unresectable NSCLC With Activating Mutation of EGFR in Exon 19 or 21(RECEL) | unknown | Phase 2 | 100 | Jinming YuOTHER | 1 | Feb 7, 2017 | clinicaltrials |
| NCT01744925 | Icotinib at Different Doses in Second-line Treatment for Non-small Cell Lung Cancer Patients With Wild Type EGFR | unknown | Phase 2 | 60 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Feb 7, 2017 | clinicaltrials |
Data updated 24 days agoSource updated Jul 24, 2017source: clinicaltrials